Cantabio Pharmaceuticals SG&A Expense (Quarterly) Trends

Cantabio Pharmaceuticals Inc (CTBO)

1.01 0.00 (0.00%) USD | OTCM | May 03, 16:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2012. Upgrade now.

Date	Value
December 31, 2018	0.16M
September 30, 2018	0.1551M
June 30, 2018	0.1247M
March 31, 2018	0.502M
December 31, 2017	0.1075M
September 30, 2017	0.1774M
June 30, 2017	0.1907M
March 31, 2017	0.2123M
December 31, 2016	0.1369M
September 30, 2016	0.2185M
June 30, 2016	0.1543M
March 31, 2016	0.2714M
December 31, 2015	0.169M
September 30, 2015	0.1502M

Date	Value
June 30, 2015	0.0945M
March 31, 2015	0.0039M
December 31, 2014	0.0061M
September 30, 2014	0.0143M
June 30, 2014	0.003M
March 31, 2014	0.0256M
December 31, 2013	0.0243M
September 30, 2013	0.0207M
June 30, 2013	0.0162M
March 31, 2013	0.02M
December 31, 2012	0.0022M
September 30, 2012	0.0025M
June 30, 2012	0.0018M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

Minimum

Maximum

Average

Median

SG&A Expense (Quarterly) Benchmarks